Stocks and InvestingStocks and Investing
Mon, October 10, 2022
Sun, October 9, 2022
Fri, October 7, 2022
Thu, October 6, 2022
Wed, October 5, 2022

David Macdonald Maintained (AMED) at Strong Buy with Decreased Target to $140 on, Oct 5th, 2022


Published on 2024-10-27 23:12:54 - WOPRAI, David Macdonald
  Print publication without navigation


David Macdonald of Truist Securities, Maintained "Amedisys, Inc." (AMED) at Strong Buy with Decreased Target from $150 to $140 on, Oct 5th, 2022.

David has made no other calls on AMED in the last 4 months.



There are 9 other peers that have a rating on AMED. Out of the 9 peers that are also analyzing AMED, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tao Qiu of "Stifel" Initiated at Hold and Held Target at $128 on, Wednesday, June 29th, 2022
  • Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $107 on, Tuesday, June 21st, 2022
  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $125 on, Tuesday, June 21st, 2022


These are the ratings of the 6 analyists that currently disagree with David


  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $135 on, Monday, October 3rd, 2022
  • Andrew Mok of "UBS" Downgraded from Hold to Strong Sell and Decreased Target to $95 on, Tuesday, August 2nd, 2022
  • John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $140 on, Monday, August 1st, 2022
  • Sarah James of "Barclays" Maintained at Buy with Decreased Target to $154 on, Friday, July 29th, 2022
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $175 on, Tuesday, June 21st, 2022
  • Joanna Gajuk of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $102 on, Tuesday, June 21st, 2022